• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢曲松在患脑膜炎儿童脑脊液中的扩散。

Ceftriaxone diffusion into cerebrospinal fluid of children with meningitis.

作者信息

Latif R, Dajani A S

出版信息

Antimicrob Agents Chemother. 1983 Jan;23(1):46-8. doi: 10.1128/AAC.23.1.46.

DOI:10.1128/AAC.23.1.46
PMID:6299184
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC184614/
Abstract

We evaluated the diffusion of ceftriaxone into the cerebrospinal fluid of 27 infants and children with meningitis who were receiving conventional antimicrobic therapy. Ceftriaxone was administered as a single 75 mg/kg dose and was given early or late or both in the course of the illness. Three hours after a dose, the mean cerebrospinal fluid ceftriaxone level was 5.7 micrograms/ml in patients studied early in the course of meningitis and 2.1 micrograms/ml in patients studied later in the illness. Six hours after a dose, the mean cerebrospinal fluid ceftriaxone levels early and late in meningitis were 7.2 and 2.5 micrograms/ml, respectively. The diffusion did not correlate with the leukocyte count or the protein or glucose content of the cerebrospinal fluid. Serial, simultaneous cerebrospinal fluid and plasma ceftriaxone levels were also determined in three additional patients with ventriculo-peritoneal shunt infections and external ventriculostomy drainage. The cerebrospinal fluid ceftriaxone levels in these patients ranged from 0.7 to 8.3 micrograms/ml. Our data indicate that ceftriaxone diffuses sufficiently and consistently into the cerebrospinal fluid to warrant its assessment in the treatment of meningitis.

摘要

我们评估了头孢曲松在27例接受传统抗菌治疗的患脑膜炎婴幼儿及儿童脑脊液中的扩散情况。头孢曲松以75mg/kg单剂量给药,在病程早期、晚期或两者均使用。给药3小时后,在脑膜炎病程早期接受研究的患者中,脑脊液头孢曲松平均水平为5.7μg/ml,在病程后期接受研究的患者中为2.1μg/ml。给药6小时后,脑膜炎早期和晚期脑脊液头孢曲松平均水平分别为7.2μg/ml和2.5μg/ml。这种扩散与脑脊液中的白细胞计数、蛋白质或葡萄糖含量无关。另外还对3例患有脑室-腹腔分流感染和脑室外引流的患者同时进行了脑脊液和血浆头孢曲松水平的系列测定。这些患者脑脊液中头孢曲松水平为0.7至8.3μg/ml。我们的数据表明,头孢曲松能充分且持续地扩散至脑脊液中,因此值得对其在脑膜炎治疗中的应用进行评估。

相似文献

1
Ceftriaxone diffusion into cerebrospinal fluid of children with meningitis.头孢曲松在患脑膜炎儿童脑脊液中的扩散。
Antimicrob Agents Chemother. 1983 Jan;23(1):46-8. doi: 10.1128/AAC.23.1.46.
2
Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis.头孢曲松治疗小儿细菌性脑膜炎的药代动力学及脑脊液杀菌活性
Antimicrob Agents Chemother. 1982 Oct;22(4):622-7. doi: 10.1128/AAC.22.4.622.
3
Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children.儿童细菌性脑膜炎治疗期间头孢噻肟和头孢曲松的脑脊液水平
Int J Antimicrob Agents. 2005 Nov;26(5):408-11. doi: 10.1016/j.ijantimicag.2005.08.005. Epub 2005 Oct 7.
4
Cefotaxime diffusion into cerebrospinal fluid of children with meningitis.头孢噻肟在患脑膜炎儿童脑脊液中的扩散。
Antimicrob Agents Chemother. 1985 Jul;28(1):138-40. doi: 10.1128/AAC.28.1.138.
5
Prospective comparative trial of ceftriaxone vs. conventional therapy for treatment of bacterial meningitis in children.头孢曲松与传统疗法治疗儿童细菌性脑膜炎的前瞻性对照试验
Pediatr Infect Dis. 1985 Jul-Aug;4(4):362-8. doi: 10.1097/00006454-198507000-00006.
6
Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children.
Clin Pharm. 1983 Nov-Dec;2(6):558-63.
7
Pharmacokinetics of ceftriaxone in pediatric patients with meningitis.头孢曲松在患脑膜炎儿科患者中的药代动力学。
Antimicrob Agents Chemother. 1983 Feb;23(2):191-4. doi: 10.1128/AAC.23.2.191.
8
[MICs and MBCs of cefotaxime, desacetylcefotaxime and ceftriaxone against four principal bacteria causing meningitis].
Jpn J Antibiot. 1984 Sep;37(9):1701-13.
9
Diffusion of ceftriaxone into the cerebrospinal fluid of adults.
J Antimicrob Chemother. 1984 Oct;14(4):427-30. doi: 10.1093/jac/14.4.427.
10
Comparison of ceftriaxone with standard therapy for bacterial meningitis.头孢曲松与细菌性脑膜炎标准疗法的比较。
J Pediatr. 1983 Jul;103(1):138-41. doi: 10.1016/s0022-3476(83)80801-4.

引用本文的文献

1
Ceftriaxone-induced Encephalopathy: A Pharmacokinetic Approach.头孢曲松诱导的脑病:一种药代动力学方法。
Eur J Case Rep Intern Med. 2021 Nov 5;8(11):003011. doi: 10.12890/2021_003011. eCollection 2021.
2
Effect of P-glycoprotein Inhibition on the Penetration of Ceftriaxone Across the Blood-Brain Barrier.P-糖蛋白抑制对头孢曲松透过血脑屏障的影响。
Neurochem Res. 2022 Mar;47(3):634-643. doi: 10.1007/s11064-021-03472-1. Epub 2021 Oct 25.
3
High-Dose Ceftriaxone for Bacterial Meningitis and Optimization of Administration Scheme Based on Nomogram.大剂量头孢曲松治疗细菌性脑膜炎及基于列线图优化给药方案
Antimicrob Agents Chemother. 2019 Aug 23;63(9). doi: 10.1128/AAC.00634-19. Print 2019 Sep.
4
Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者静脉注射头孢曲松后的全身药代动力学及脑脊液摄取情况
J Clin Pharmacol. 2014 Oct;54(10):1180-7. doi: 10.1002/jcph.317. Epub 2014 May 16.
5
Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.抗菌药物在脑脊液中的临床药代动力学。
Clin Pharmacokinet. 2013 Jul;52(7):511-42. doi: 10.1007/s40262-013-0062-9.
6
Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.药物穿透血脑屏障/血脑脊液屏障以治疗中枢神经系统感染。
Clin Microbiol Rev. 2010 Oct;23(4):858-83. doi: 10.1128/CMR.00007-10.
7
Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievable in cerebrospinal fluid.曲伐沙星单独及与β-内酰胺类药物、利福平或万古霉素联合使用时,针对在脑脊液中可达到的临床浓度下对超广谱头孢菌素具有不同敏感性的肺炎链球菌分离株的杀菌活性。
Antimicrob Agents Chemother. 1999 Oct;43(10):2372-5. doi: 10.1128/AAC.43.10.2372.
8
Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges.头孢噻肟和头孢曲松在未发炎脑膜患者脑脊液中的透过情况。
Antimicrob Agents Chemother. 1993 Jul;37(7):1518-24. doi: 10.1128/AAC.37.7.1518.
9
Concentrations of ceftriaxone in cerebrospinal fluid of children with meningitis receiving dexamethasone therapy.接受地塞米松治疗的脑膜炎患儿脑脊液中头孢曲松的浓度。
Antimicrob Agents Chemother. 1994 May;38(5):1209-10. doi: 10.1128/AAC.38.5.1209.
10
In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis.脑脊液中临床可达到浓度的抗生素对从脑膜炎患儿分离出的耐青霉素肺炎链球菌的体外杀伤活性。
Antimicrob Agents Chemother. 1994 Nov;38(11):2655-9. doi: 10.1128/AAC.38.11.2655.

本文引用的文献

1
Treatment of purulent meningitis with a new cephalosporin-Rocephin (Ro 13-9904). Clinical, bacteriological and pharmacological observations in 24 cases.用新型头孢菌素——罗氏芬(Ro 13 - 9904)治疗化脓性脑膜炎。24例临床、细菌学及药理学观察
Chemotherapy. 1981;27 Suppl 1:57-61. doi: 10.1159/000238030.
2
Diffusion of ceftriaxone (Ro 13-9004/001) in the cerebrospinal fluid. Comparison with other beta-lactam antibiotics in dogs with healthy meninges and in dogs with experimental meningitis.头孢曲松(Ro 13-9004/001)在脑脊液中的扩散。与其他β-内酰胺类抗生素在健康脑膜犬和实验性脑膜炎犬中的比较。
Chemotherapy. 1981;27 Suppl 1:37-41. doi: 10.1159/000238027.
3
Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.头孢曲松(Ro 13 - 9904)的抗菌活性,一种对β-内酰胺酶稳定的头孢菌素。
Antimicrob Agents Chemother. 1981 Mar;19(3):414-23. doi: 10.1128/AAC.19.3.414.
4
Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.头孢哌酮、头孢曲松和拉氧头孢在实验性肺炎链球菌和流感嗜血杆菌脑膜炎中的药代动力学及细菌学疗效
Antimicrob Agents Chemother. 1982 Feb;21(2):262-7. doi: 10.1128/AAC.21.2.262.
5
Single-dose pharmacokinetics of ceftriaxone in infants and young children.头孢曲松在婴幼儿中的单剂量药代动力学。
Antimicrob Agents Chemother. 1982 Feb;21(2):248-53. doi: 10.1128/AAC.21.2.248.
6
Pharmacokinetics of ceftriaxone in humans.头孢曲松在人体内的药代动力学。
Antimicrob Agents Chemother. 1981 Nov;20(5):634-41. doi: 10.1128/AAC.20.5.634.
7
Comparative in-vitro activity and mode of action of ceftriaxone (Ro 13-9904), a new highly potent cephalosporin.
J Antimicrob Chemother. 1981 Sep;8(3):193-203. doi: 10.1093/jac/8.3.193.